Enzyme replacement therapy in Fabry disease: Comparison of agalsidase alfa and agalsidase beta

被引：20
|
作者：
Mehta, Atul [1 ]
Beck, Michael [2 ]
Kampmann, Christoph [2 ]
Frustaci, Andrea [3 ]
Germain, Dominique P. [4 ]
Pastores, Gregory M. [5 ]
Sunder-Plassmann, Gere [6 ]
机构：
[1] UCL Royal Free & Univ Coll Med Sch, Dept Acad Haematol, London NW3 2QG, England
[2] Univ Childrens Hosp, Mainz, Germany
[3] Univ Roma La Sapienza, Heart & Great Vessels Attilio Reale Dept, Rome, Italy
[4] Univ Versailles St Quentin Yvelines, Hop Raymond Poincare, AP HP, UF Genet Med, Garches, France
[5] NYU, Sch Med, Dept Neurol & Pediat, New York, NY USA
[6] Dept Internal Med 3, Div Nephrol & Dialysis, Vienna, Austria
来源：
MOLECULAR GENETICS AND METABOLISM | 2008年 / 95卷 / 1-2期
关键词：
D O I：
10.1016/j.ymgme.2008.07.002
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：114 / 115
页数：2
相关论文
共 50 条
  • [1] Agalsidase alfa for enzyme-replacement therapy in Fabry disease
    Mehta, Atul
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (05) : 641 - 652
  • [2] Clinical observations on enzyme replacement therapy in patients with Fabry disease and the switch from agalsidase beta to agalsidase alfa
    Abcde, Hsiang-Yu Lin
    Huang, Yu-Hsiu
    Liao, Hsuan-Chieh
    Liu, Hao-Chuan
    Hsu, Ting-Rong
    Shen, Chia-I
    Li, Shao-Tzu
    Li, Cheng-Fang
    Lee, Li-Hong
    Lee, Pi-Chang
    Huang, Chun-Kai
    Chiang, Chuan-Chi
    Lin, Shuan-Pei
    Niu, Dau-Ming
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2014, 77 (04) : 190 - 197
  • [3] Enzyme replacement therapy with agalsidase alfa in children with Fabry disease
    Ramaswami, U.
    Wendt, S.
    Pintos-Morell, G.
    Parini, R.
    Whybra, C.
    Leon Leal, J. A.
    Santus, F.
    Beck, M.
    ACTA PAEDIATRICA, 2007, 96 (01) : 122 - 127
  • [4] SWITCH FROM AGALSIDASE BETA TO AGALSIDASE ALFA IN THE ENZYME REPLACEMENT THERAPY OF PATIENTS WITH FABRY DISEASE IN LATIN AMERICA
    Ripeau, Diego
    Amartino, Hernan
    Cedrolla, Martin
    Urtiaga, Luis
    Urdaneta, Bella
    Cano, Marilis
    Valdez, Rita
    Antongiovanni, Norberto
    Masllorens, Francisca
    MEDICINA-BUENOS AIRES, 2017, 77 (03) : 173 - 179
  • [5] AGALSIDASE ALFA AND AGALSIDASE BETA FOR TREATMENT OF FABRY DISEASE
    Costa, M. G.
    Santos, M.
    Senna, K.
    VALUE IN HEALTH, 2018, 21 : S439 - S440
  • [6] SAFETY OF ENZYME REPLACEMENT THERAPY WITH AGALSIDASE ALFA IN CHILDREN WITH FABRY DISEASE
    Ramaswami, U.
    Wendt, S.
    Parini, R.
    Pintos, G.
    Leon, J. A.
    Santus, F.
    Whybra, C.
    Beck, M.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2005, 28 : 167 - 167
  • [7] Prospective Results of Switching Enzyme Replacement Therapy from Agalsidase beta to Agalsidase alfa in the Canadian Fabry Disease Initiative Study
    West, Michael
    Bichet, Daniel
    Casey, Robin
    Clarke, Joe
    Sirrs, Sandra
    Flowerdew, Gordon
    LeMoine, Kaye
    MOLECULAR GENETICS AND METABOLISM, 2012, 105 (02) : S64 - S65
  • [8] Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease
    Ries, Markus
    Clarke, Joe T. R.
    Whybra, Catharina
    Timmons, Margaret
    Robinson, Chevalia
    Schlaggar, Bradley L.
    Pastores, Gregory
    Lien, Y. Howard
    Kampmann, Christoph
    Brady, Roscoe O.
    Beck, Michael
    Schiffmann, Raphael
    PEDIATRICS, 2006, 118 (03) : 924 - 932
  • [9] The use of agalsidase alfa enzyme replacement therapy in the treatment of Fabry disease
    Morell, Chantal F.
    Clarke, Joe T. R.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2009, 9 (05) : 631 - 639
  • [10] Enzyme replacement therapy with agalsidase alfa in pregnant women with Fabry disease
    Kalkum, G.
    Macchiella, D.
    Reinke, J.
    Koelbl, H.
    Beck, M.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2009, 144 (01) : 92 - 93
12345